GNAIDec 21, 2023

Preparing to Integrate Generative Pretrained Transformer Series 4 models into Genetic Variant Assessment Workflows: Assessing Performance, Drift, and Nondeterminism Characteristics Relative to Classifying Functional Evidence in Literature

Microsoft
arXiv:2312.13521v24 citationsh-index: 14
Originality Synthesis-oriented
AI Analysis

This addresses the challenge of integrating LLMs into clinical genetic workflows, though it is incremental as it focuses on assessing existing models rather than developing new methods.

The study assessed GPT-4's performance, nondeterminism, and drift for classifying functional evidence in genetic variant literature, finding substantial variability over time but achieving up to 92.2% sensitivity for identifying relevant articles and 90.0% sensitivity for pathogenic evidence classification.

Background. Large Language Models (LLMs) hold promise for improving genetic variant literature review in clinical testing. We assessed Generative Pretrained Transformer 4's (GPT-4) performance, nondeterminism, and drift to inform its suitability for use in complex clinical processes. Methods. A 2-prompt process for classification of functional evidence was optimized using a development set of 45 articles. The prompts asked GPT-4 to supply all functional data present in an article related to a variant or indicate that no functional evidence is present. For articles indicated as containing functional evidence, a second prompt asked GPT-4 to classify the evidence into pathogenic, benign, or intermediate/inconclusive categories. A final test set of 72 manually classified articles was used to test performance. Results. Over a 2.5-month period (Dec 2023-Feb 2024), we observed substantial differences in intraday (nondeterminism) and across day (drift) results, which lessened after 1/18/24. This variability is seen within and across models in the GPT-4 series, affecting different performance statistics to different degrees. Twenty runs after 1/18/24 identified articles containing functional evidence with 92.2% sensitivity, 95.6% positive predictive value (PPV) and 86.3% negative predictive value (NPV). The second prompt's identified pathogenic functional evidence with 90.0% sensitivity, 74.0% PPV and 95.3% NVP and for benign evidence with 88.0% sensitivity, 76.6% PPV and 96.9% NVP. Conclusion. Nondeterminism and drift within LLMs must be assessed and monitored when introducing LLM based functionality into clinical workflows. Failing to do this assessment or accounting for these challenges could lead to incorrect or missing information that is critical for patient care. The performance of our prompts appears adequate to assist in article prioritization but not in automated decision making.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes